Clinical trials
Immune System Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 13 |
| Recruiting | 8 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Novartis Pharmaceuticals | 3 |
| Celgene | 2 |
| Cogent Biosciences, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Imagine Institute | 2 |
| University Hospital, Bordeaux | 2 |
| Viatris Innovation GmbH | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Adienne SA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 45 |
| Autoimmune Diseases | 18 |
| Lupus Erythematosus, Systemic | 9 |
| Lymphoproliferative Disorders | 9 |
| Connective Tissue Diseases | 8 |
| Lymphatic Diseases | 7 |
| Lymphoma | 7 |
| Neoplasms | 7 |
| Nervous System Diseases | 7 |
| Hypersensitivity | 6 |
Trials
Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.